[{"orgOrder":0,"company":"University of Surrey","sponsor":"FrieslandCampina","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"UNITED KINGDOM","productType":"Dietary Supplement","year":"2019","type":"Inapplicable","leadProduct":"4'-Galactooligosaccharide","moa":"Undisclosed","graph1":"Psychiatry\/Psychology","graph2":"Undisclosed","graph3":"University of Surrey","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Surrey \/ FrieslandCampina","highestDevelopmentStatusID":"1","companyTruncated":"University of Surrey \/ FrieslandCampina"},{"orgOrder":0,"company":"Clasado","sponsor":"CR2O B.V.","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"UNITED KINGDOM","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"4'-Galactooligosaccharide","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"Clasado","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Clasado \/ CR2O B.V.","highestDevelopmentStatusID":"1","companyTruncated":"Clasado \/ CR2O B.V."},{"orgOrder":0,"company":"University of Aberdeen","sponsor":"YAKULT HONSHA CO LTD","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"UNITED KINGDOM","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"4'-Galactooligosaccharide","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"University of Aberdeen","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Aberdeen \/ YAKULT HONSHA CO LTD","highestDevelopmentStatusID":"1","companyTruncated":"University of Aberdeen \/ YAKULT HONSHA CO LTD"},{"orgOrder":0,"company":"University of Reading","sponsor":"Clasado Research Services Ltd","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"UNITED KINGDOM","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"4'-Galactooligosaccharide","moa":"Undisclosed","graph1":"Psychiatry\/Psychology","graph2":"Undisclosed","graph3":"University of Reading","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Reading \/ Clasado Research Services Ltd","highestDevelopmentStatusID":"1","companyTruncated":"University of Reading \/ Clasado Research Services Ltd"},{"orgOrder":0,"company":"University of Florida","sponsor":"GTC Nutrition","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Dietary Supplement","year":"2010","type":"Inapplicable","leadProduct":"4'-Galactooligosaccharide","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"University of Florida","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Florida \/ GTC Nutrition","highestDevelopmentStatusID":"1","companyTruncated":"University of Florida \/ GTC Nutrition"},{"orgOrder":0,"company":"University of Florida","sponsor":"GTC Nutrition","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Dietary Supplement","year":"2011","type":"Inapplicable","leadProduct":"4'-Galactooligosaccharide","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"University of Florida","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Florida \/ GTC Nutrition","highestDevelopmentStatusID":"1","companyTruncated":"University of Florida \/ GTC Nutrition"}]

Find Clinical Drug Pipeline Developments & Deals for 4'-Galactooligosaccharide

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          University of Reading

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          University of Reading

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          Details : Galactooligosaccharide is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Stress.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          May 25, 2025

                          Lead Product(s) : 4'-Galactooligosaccharide

                          Therapeutic Area : Psychiatry/Psychology

                          Highest Development Status : Undisclosed

                          Sponsor : Clasado Research Services Ltd

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          University of Aberdeen

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          University of Aberdeen

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          Details : Galactooligosaccharide is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Hyperglycemia.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          December 03, 2024

                          Lead Product(s) : 4'-Galactooligosaccharide

                          Therapeutic Area : Endocrinology

                          Highest Development Status : Undisclosed

                          Sponsor : YAKULT HONSHA CO LTD

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          Clasado

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          Clasado

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          Details : Galactooligosaccharide is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Irritable Bowel Syndrome.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          December 14, 2021

                          Lead Product(s) : 4'-Galactooligosaccharide

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Undisclosed

                          Sponsor : CR2O B.V.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          University of Surrey

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          University of Surrey

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          Details : Galactooligosaccharide is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Anxiety.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          February 08, 2019

                          Lead Product(s) : 4'-Galactooligosaccharide

                          Therapeutic Area : Psychiatry/Psychology

                          Highest Development Status : Undisclosed

                          Sponsor : FrieslandCampina

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          University of Florida

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          University of Florida

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          Details : Galactooligosaccharide is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          February 24, 2011

                          Lead Product(s) : 4'-Galactooligosaccharide

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : GTC Nutrition

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          University of Florida

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          University of Florida

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          Details : Galactooligosaccharide is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          June 04, 2010

                          Lead Product(s) : 4'-Galactooligosaccharide

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : GTC Nutrition

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank